| For: | Tantai XX, Yang LB, Wei ZC, Xiao CL, Chen LR, Wang JH, Liu N. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis. World J Gastroenterol 2019; 25(21): 2683-2698 [PMID: 31210719 DOI: 10.3748/wjg.v25.i21.2683] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i21/2683.htm |
| Number | Citing Articles |
| 1 |
Akira Sakamaki, Kenya Kamimura, Takeshi Yokoo, Akihiko Osaki, Seiichi Yoshikawa, Yoshihisa Arao, Toru Setsu, Hiroteru Kamimura, Nobuo Waguri, Manabu Takeuchi, Kazuhiro Funakoshi, Shuji Terai. The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors. Medicine 2021; 100(32) doi: 10.1097/MD.0000000000026902
|
| 2 |
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk management. Terapevticheskii arkhiv 2021; 93(8) doi: 10.26442/00403660.2021.08.200917
|
| 3 |
Florent Broca, Mylène Dufrenoy, Mickaël Martin. Prise en charge de l’encéphalopathie hépatique : revue générale. La Revue de Médecine Interne 2025; 46(4) doi: 10.1016/j.revmed.2024.10.007
|
| 4 |
Nisar Amin, Harleen Chela, Muhammad Faisal Mubarak, Mark Ayoub, Ebubekir Daglilar. Proton Pump Inhibitor Use Following Esophageal Variceal Ligation and Its Impact on Clinical Outcomes: Real-World Data from the TriNetX Global Collaborative Network. Diagnostics 2025; 15(13) doi: 10.3390/diagnostics15131653
|
| 5 |
Ummi Maimunah, Andreas Agung Kurniawan, Andrio Palayukan. Adverse Effects of Long-term Proton Pump Inhibitors in Chronic Liver Disease Patients – A Preliminary Article Review. Review of Clinical Pharmacology and Pharmacokinetics - International Edition 2024; 38(1) doi: 10.61873/WWAY6273
|
| 6 |
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liver. Journal of Digestive Diseases 2022; 23(4) doi: 10.1111/1751-2980.13093
|
| 7 |
晶今 邓. Research Progress on Treatment Measures for Hepatic Encephalopathy. Advances in Clinical Medicine 2026; 16(06) doi: 10.12677/acm.2026.1662314
|
| 8 |
Maria de Brito Nunes, Matthias Knecht, Reiner Wiest, Jaume Bosch, Annalisa Berzigotti. Predictors and management of post‐banding ulcer bleeding in cirrhosis: A systematic review and meta‐analysis. Liver International 2023; 43(8) doi: 10.1111/liv.15621
|
| 9 |
Naina Mohamed Pakkir Maideen. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors. Chonnam Medical Journal 2023; 59(2) doi: 10.4068/cmj.2023.59.2.115
|
| 10 |
Mette Munk Lauridsen, Elise Jonasson, Jasmohan S. Bajaj. Microbial Approaches to Treat and Prevent Hepatic Encephalopathy. Gastroenterology Clinics of North America 2025; 54(2) doi: 10.1016/j.gtc.2024.12.006
|
| 11 |
Jun Sik Yoon, Ji Hoon Hong, Soo Young Park, Seung Up Kim, Hwi Young Kim, Ju Yeon Kim, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Han Ah Lee, Gi‐Ae Kim, Dong Hyun Sinn, Sung Jae Park, Youn Jae Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee. High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study. Alimentary Pharmacology & Therapeutics 2024; 59(8) doi: 10.1111/apt.17909
|
| 12 |
Pan Zhang, Lizhi Zhou, Li Chen, Zhen Zhang, Rui Han, Gangwen Guo, Haocheng Zhou. Electroencephalography Signatures for Hepatic Encephalopathy in Cirrhosis Patients Treated with Proton Pump Inhibitors: An Exploratory Pilot Study. Biomedicines 2022; 10(12) doi: 10.3390/biomedicines10123040
|
| 13 |
Agastya Patel, Piotr Spychalski, Jarek Kobiela. Letter: mind the gap – search and publication date of systematic reviews and meta‐analysis. Alimentary Pharmacology & Therapeutics 2021; 54(5) doi: 10.1111/apt.16537
|
| 14 |
Yun Su, Yueqiao Chen, Jinghui Zheng, Chun Yao. Association between proton pump inhibitors and risk of hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt: a protocol for a systematic review and meta-analysis. BMJ Open 2024; 14(4) doi: 10.1136/bmjopen-2023-078412
|
| 15 |
Rui Dai, Alan A. Sag, Jonathan G. Martin, Nicholas T. Befera, Waleska M. Pabon-Ramos, Paul V. Suhocki, Tony P. Smith, Charles Y. Kim, Andrew J. Muir, James Ronald. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort. Clinical Imaging 2021; 77 doi: 10.1016/j.clinimag.2021.04.034
|
| 16 |
Hsin-Ni Shih, Chung-Hsuen Wu, Yuan-Wen Lee, Chun-Chao Chang. Association between anticholinergic drug use and hepatic encephalopathy risk among patients with cirrhosis. Journal of the Formosan Medical Association 2025; doi: 10.1016/j.jfma.2025.06.038
|
| 17 |
Rok Orel, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Alexandra Papadopoulou, Carmen Ribes‐Koninckx, Mike Thomson, Michael Wilschanski, Nikhil Thapar. Drugs in Focus. Journal of Pediatric Gastroenterology and Nutrition 2021; 72(5) doi: 10.1097/MPG.0000000000003063
|
| 18 |
Halil Atasoy, Arzu Levent. The effect of the use of proton pump inhibitors (PPI) on complications in patients with cirrhosis. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-025-04516-4
|
| 19 |
K. Toda. Are proton pump inhibitors suitable medicines to prevent upper gastrointestinal events due to non-steroidal anti-inflammatory drugs?. Osteoarthritis and Cartilage 2020; 28(1) doi: 10.1016/j.joca.2019.09.010
|
| 20 |
Carlos Martín de Argila de Prados, Julia Lopez Cardona, Federico Argüelles-Arias. Safe use of proton-pump inhibitors. Revista Española de Enfermedades Digestivas 2023; 115 doi: 10.17235/reed.2023.9834/2023
|
| 21 |
Xiaoli Wu, Daofu Zhang, Yuexiao Yu, Lianqing Lou, Xiaofei Li. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20193890
|
| 22 |
Reidar Fossmark, Tom C. Martinsen, Helge L. Waldum. Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility. International Journal of Molecular Sciences 2019; 20(20) doi: 10.3390/ijms20205203
|
| 23 |
Haijuan Yao, Hongyu Li, Zhuang Ma, Yanyan Wu, Yufu Tang, Hao Meng, Hao Yu, Chengfei Peng, Yue Teng, Quanyu Zhang, Tianyi Zhu, Haitao Zhao, Guiyang Chu, Zhenhua Tong, Lu Liu, Hui Lu, Xingshun Qi. Impact of proton pump inhibitors on the in-hospital outcome of COVID-19 patients: a retrospective study. Therapeutic Advances in Gastroenterology 2022; 15 doi: 10.1177/17562848221104365
|
| 24 |
A.M. Osadchuk, I.D. Loranskaya, M.A. Osadchuk, L.R. Khamatnurova. Proton pump inhibitors: positive and negative properties. On the 45th anniversary of their discovery. Russian Journal of Preventive Medicine 2024; 27(11) doi: 10.17116/profmed202427111135
|
| 25 |
Gasser El-Azab. Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks. Current Gastroenterology Reports 2024; 26(12) doi: 10.1007/s11894-024-00943-7
|